HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akifumi Nozawa Selected Research

Essential Osteolysis

1/2019The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
5/2016Gorham-Stout Disease of the Skull Base With Hearing Loss: Dramatic Recovery and Antiangiogenic Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akifumi Nozawa Research Topics

Disease

3Neuroblastoma
01/2020 - 11/2018
2Glioblastoma (Glioblastoma Multiforme)
11/2020 - 07/2019
2Neoplasms (Cancer)
01/2020 - 01/2017
2Essential Osteolysis
01/2019 - 05/2016
1Cytopenia
11/2020
1Ring Chromosomes (Ring Chromosome)
11/2020
1Anemia
11/2020
1Astrocytoma (Pilocytic Astrocytoma)
11/2020
1Neuroepithelial Neoplasms (Gliomatosis Cerebri)
11/2020
1Chromosome Aberrations (Chromosome Abnormalities)
11/2020
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2020
1Cri-du-Chat Syndrome (5p- Syndrome)
11/2020
1Disease Progression
11/2020
1Blue rubber bleb nevus syndrome
01/2020
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2020
1Brain Neoplasms (Brain Tumor)
01/2020
1Infections
01/2020
1Pleural Effusion (Pleural Effusions)
11/2019
1Lung Neoplasms (Lung Cancer)
07/2019
1Thrombotic Microangiopathies
11/2018
1Kasabach-Merritt Syndrome
09/2018
1Stomatitis
08/2018
1Hematologic Neoplasms (Hematological Malignancy)
08/2018
1Hemangioendothelioma
01/2017
1Hemangioma (Angioma)
11/2016
1Hearing Loss (Hearing Impairment)
05/2016

Drug/Important Bio-Agent (IBA)

4Sirolimus (Rapamycin)FDA Link
01/2020 - 09/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020 - 11/2016
1chenodeoxycholate sulfate conjugate (CDCS)IBA
11/2020
1Azacitidine (5 Azacytidine)FDA Link
11/2020
1Bevacizumab (Avastin)FDA Link
11/2020
1CytokinesIBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
11/2019
1Cell-Free Nucleic AcidsIBA
11/2019
1Phosphotransferases (Kinase)IBA
07/2019
1AcidsIBA
07/2019
1Proteins (Proteins, Gene)FDA Link
07/2019
1perampanelIBA
07/2019
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
07/2019
1CaspasesIBA
07/2019
1eculizumabFDA Link
11/2018
1AutoantibodiesIBA
11/2018
1Complement Factor H (Factor H)IBA
11/2018
1Complement System Proteins (Complement)IBA
11/2018
1azuleneIBA
08/2018
1AlginatesIBA
08/2018
1polaprezinc (Z 103)IBA
08/2018
1SuspensionsIBA
08/2018
1TOR Serine-Threonine KinasesIBA
01/2017
1EverolimusFDA Link
01/2017
1Propranolol (Inderal)FDA LinkGeneric
11/2016

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2020 - 08/2018
2Therapeutics
11/2018 - 05/2016
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
11/2018
1Hematopoietic Stem Cell Transplantation
08/2018
1Radiotherapy
08/2018
1Stem Cell Transplantation
08/2018